APPLICATION
ANDA201784
TYPE
ANDA
ORIGINAL APPROVAL
2012-01-30
LATEST ACTION
2024-12-11
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription
Products
CYTARABINEPrescription
CYTARABINE 100MG/ML · INJECTABLE · INJECTION
Approval history
2024-12-11Labeling · Supplement 7 · standardAP
2024-12-11Labeling · Supplement 4 · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.